Analysis of Anti-HLA Antibodies in Sensitized Kidney Transplant Candidates Subjected to Desensitization with Intravenous Immunoglobulin and Rituximab
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analysis of Anti-HLA Antibodies in Sensitized Kidney Transplant Candidates Subjected to Desensitization with Intravenous Immunoglobulin and Rituximab
Authors
Keywords
-
Journal
TRANSPLANTATION
Volume 96, Issue 2, Pages 182-190
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-06-18
DOI
10.1097/tp.0b013e3182962c84
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BAFF and BAFF-R Levels Are Associated With Risk of Long-Term Kidney Graft Dysfunction and Development of Donor-Specific Antibodies
- (2012) A. Thibault-Espitia et al. AMERICAN JOURNAL OF TRANSPLANTATION
- B-cell populations and sub-populations in Sjögren's syndrome
- (2012) Nishath Hamza et al. PRESSE MEDICALE
- Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy
- (2012) Christian Morath et al. TRANSPLANT INTERNATIONAL
- Lack of Effect in Desensitization With Intravenous Immunoglobulin and Rituximab in Highly Sensitized Patients
- (2012) Kwaku Marfo et al. TRANSPLANTATION
- Desensitizing the Broadly Human Leukocyte Antigen–Sensitized Patient Awaiting Deceased Donor Kidney Transplantation
- (2012) S.C. Jordan et al. TRANSPLANTATION PROCEEDINGS
- Clinical Relevance of Pretransplant HLA Class II Donor-specific Antibodies in Renal Transplantation Patients with Negative T-cell Cytotoxicity Crossmatches
- (2012) Eun Young Song et al. Annals of Laboratory Medicine
- In Vitro Effects of Rituximab on the Proliferation, Activation and Differentiation of Human B Cells
- (2011) E. G. Kamburova et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Targeting B Cells and Antibody in Transplantation
- (2011) M. R. Clatworthy AMERICAN JOURNAL OF TRANSPLANTATION
- Desensitization Protocols and Their Outcome
- (2011) K. Marfo et al. Clinical Journal of the American Society of Nephrology
- Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation
- (2011) Stanley C Jordan et al. Expert Review of Clinical Immunology
- Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation
- (2011) J. L. Caro-Oleas et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Desensitization in HLA-Incompatible Kidney Recipients and Survival
- (2011) Robert A. Montgomery et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current approaches to the management of highly sensitized kidney transplant patients
- (2011) C. Süsal et al. TISSUE ANTIGENS
- Kidney Transplantation for High-Risk Sensitized Patients – The “Heidelberg Algorithm”
- (2011) C. Morath et al. TRANSPLANTATION PROCEEDINGS
- Making Sense of Desensitization
- (2010) H. M. Gebel et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Bortezomib as the Sole Post-Renal Transplantation Desensitization Agent Does Not Decrease Donor-Specific Anti-HLA Antibodies
- (2010) R. Sberro-Soussan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antiallograft antibodies: relevance, detection, and monitoring
- (2010) Mary S Leffell et al. Current Opinion in Organ Transplantation
- Targeting B cells in sensitized kidney transplant patients: state of the art and future perspectives
- (2010) Renaud Snanoudj et al. Current Opinion in Organ Transplantation
- 89-P: Human Monoclonal Antibody Reactivity With HLA Class I Epitopes Defined by Eplet Pairs
- (2010) Rene J. Duquesnoy et al. HUMAN IMMUNOLOGY
- Identification of a B cell signature associated with renal transplant tolerance in humans
- (2010) Kenneth A. Newell et al. JOURNAL OF CLINICAL INVESTIGATION
- Desensitization for renal transplantation: depletion of donor-specific anti-HLA antibodies, preservation of memory antibodies, and clinical risks
- (2010) Natasha M. Rogers et al. TRANSPLANT INTERNATIONAL
- Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation
- (2010) Ashley A. Vo et al. TRANSPLANTATION
- Effects of Sample Timing and Treatment on Gene Expression in Early Acute Renal Allograft Rejection
- (2010) Oliver P. Günther et al. TRANSPLANTATION
- Proinflammatory Events Are Associated with Significant Increases in Breadth and Strength of HLA-Specific Antibody
- (2009) J. E. Locke et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Positive Cross-Match Living Donor Kidney Transplantation: Longer-Term Outcomes
- (2009) A. Haririan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Management of the highly sensitized patient
- (2009) Frans HJ Claas et al. CURRENT OPINION IN IMMUNOLOGY
- Antibodies, isotypes and complement in allograft rejection
- (2009) Georg A Böhmig et al. Current Opinion in Organ Transplantation
- Effect of desensitization in solid organ transplant recipients depends on some cytokines genes polymorphism
- (2009) A.L. Lobashevsky et al. TRANSPLANT IMMUNOLOGY
- BAFF May Modulate the Rate of B-Cell Repopulation After Rituximab Therapy for Acute Renal Transplant Rejection
- (2009) Valeriya Zarkhin et al. TRANSPLANTATION
- Functional Genomic Analysis of Peripheral Blood During Early Acute Renal Allograft Rejection
- (2009) Oliver P. Günther et al. TRANSPLANTATION
- Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production
- (2008) D. K. Perry et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
- (2008) Ashley A. Vo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acceptable Donor-Specific Antibody Levels Allowing for Successful Deceased and Living Donor Kidney Transplantation After Desensitization Therapy
- (2008) Nancy L. Reinsmoen et al. TRANSPLANTATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started